Lavivo is a biotechnology company developing preventions and treatments for people who suffer from gastrointestinal (GI) unbalances and infections impacting the bodily function. It has developed the QUALVIVO bacterial system as platform for live bacterial therapy, delivering live beneficial bacteria, harnessing the power of the human microbiome.
Through close cooperation with scientists and experts within the focused technologies Lavivo can offer products and concepts based on the latest developments in research.
For more about the Qualvivo system concept.
For more about the AptiCare® products.
Lavivo is situated in Gothenburg, on the west coast of Sweden.